A sensor-assisted walking program for older adults with osteoporosis
Tests a walking program using a heel sensor in older adults with osteoporosis.
Plain-language title generated from the registry record
Registry title: People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk
Key facts
- Where
- Montreal, CanadaSee the site
Where in Canada
- Research Institute of the McGill University Health CentreMontreal, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Trial code
- NCT07621679
- Record updated
- 2 June 2026
- Original description
The aim of the Walk BEST study is to provide evidence that it is feasible to implement the technology assisted gait- focused walking program Walk-BEST™ in older adults with osteoporosis, and that this program is acceptable to this population.Read full original descriptionShow less
People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk
The aim of the Walk BEST study is to provide evidence that it is feasible to implement the technology assisted gait- focused walking program Walk-BEST™ in older adults with osteoporosis, and that this program is acceptable to this population.
Inclusion: men and women 70 years and older; able to walk independently with or without a walking aid; experienced a prior fracture after the age of 40, OR two falls in the past 12 months, OR who have a bone mineral density test (done as part of routine clinical evaluation) with a T-score < -2.5, OR on a Health Canada-approved anti-osteoporosis medication (oral or intravenous bisphosphonate, denosumab, teriparatide, or romozosumab) to reduce fracture risk or on a bisphosphonate drug holiday (planned treatment interruption).
Exclusion: fracture sustained in the past 12 months; unable to walk unsupervised because of active medical or neurocognitive reasons; unable to provide informed consent, or cannot communicate in English or French.